Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Kindeva announced the promotion of David Stevens, Chief Operating and Commercial Officer, to the newly created role of President. In this capacity, David will lead Kindeva’s global operations.
read more
Thursday, October 23, 2025
Samsung Biologics announced a shareholder-approved split of its business divisions, positioning itself as a pure-play contract development and manufacturing organization (CDMO). The move, passed with 99.9% approval at an extraordinary shareholders’ ...
read more
Thursday, October 23, 2025
AGC Biologics has entered into an agreement with Rarity PBC to develop and manufacture RDP-101, a breakthrough gene therapy targeting Adenosine Deaminase Severe Combined Immunodeficiency Disorder (ADA-SCID), also known as “Bubble Baby Disease”.
read more
Thursday, October 23, 2025
Aenova announced a major investment in its sterile manufacturing capabilities with the installation of another fill & finish (F&F) line at its Latina site. This expansion marks a significant step in meeting the growing global demand for biologics ...
read more
Wednesday, October 22, 2025
Cambrex announced a $120 million investment aimed at expanding active pharmaceutical ingredient (API) manufacturing capacity in the United States, reinforcing domestic supply chain resilience and supporting the growing peptide therapeutics segment.
read more
Wednesday, October 22, 2025
Serán BioScience has announced an expansion of its commercial manufacturing footprint with the development of a new 100,000-square-foot campus in Bend, Oregon.
read more
Tuesday, October 21, 2025
Peli BioThermal, a provider of temperature-controlled packaging solutions, has completed a major expansion of its Frankfurt Service Center, tripling its operational capacity to meet accelerating demand across Europe’s pharmaceutical and life sciences...
read more
Tuesday, October 21, 2025
Upperton Pharma Solutions has expanded its GMP manufacturing capabilities with the installation of a Fill2Weight gravimetric powder filling system from 3P innovation at its 60,000-square-foot facility in Nottingham, UK.
read more
Tuesday, October 21, 2025
Ajinomoto Bio-Pharma Services and Gene Tools have announced a collaboration to expand access to phosphorodiamidate morpholino oligomer (PMO) therapeutics, a growing class of oligonucleotide drugs that show promise in treating genetic diseases such as...
read more
Tuesday, October 21, 2025
Stevanato Group announced a significant expansion of its drug delivery systems manufacturing capacity at its Bad Oeynhausen facility in northern Germany, reinforcing the company’s global integration strategy across the pharmaceutical and ...
read more
Swiss medical device manufacturer Ypsomed AG has announced a $248 million investment to establish its first manufacturing facility in the United States, marking a major milestone in the company’s international expansion strategy.
read more
Charles River Laboratories has appointed former FDA Principal Deputy Commissioner Namandjé N. Bumpus, Ph.D., to chair its newly established Scientific Advisory Board, guiding the company’s strategy to advance New Approach Methodologies (NAMs) that ...
read more
Wednesday, October 15, 2025
Sterling Pharma Solutions announced Karl Rotthier as CEO, effective October, 21st. Rotthier succeeds Kevin Cook, who has served as CEO since 2013 and has now taken the decision to retire. Kevin will work closely with Karl to ensure a smooth ...
read more
Wednesday, October 15, 2025
MilliporeSigma announced that the Life Science business of Merck KGaA, Darmstadt, Germany has signed a definitive agreement to acquire the chromatography business of JSR Life Sciences, a provider of contract development and manufacturing, preclinical...
read more
Wednesday, October 15, 2025
LTS LOHMANN Therapie-Systeme AG announced the acquisition of Renaissance Lakewood, a US-based contract development and manufacturing organization (CDMO) specializing in nasal sprays and sterile dosage forms.
read more